We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCO icon
1051
Clear Channel Outdoor Holdings
CCO
$1.23B
$240K 0.03%
69,505
-156,975
-69% -$533K
NGNE icon
1052
Neurogene
NGNE
$712M
$240K 0.03%
6,394
-151
-2% -$8.81K
UPS icon
1053
United Parcel Service
UPS
$88.9B
$240K 0.03%
+1,119
New +$238K
HRT
1054
DELISTED
HireRight Holdings Corporation
HRT
$240K 0.03%
+14,022
New +$189K
EMWP
1055
DELISTED
Eros Media World PLC
EMWP
$240K 0.03%
86,034
+21,967
+34% +$91.6K
PLAN
1056
DELISTED
Anaplan, Inc.
PLAN
$239K 0.03%
+3,675
New +$179K
AGR
1057
DELISTED
Avangrid, Inc.
AGR
$238K 0.03%
+5,093
New +$233K
KBAL
1058
DELISTED
Kimball International
KBAL
$238K 0.03%
28,213
-15,816
-36% -$150K
BKH icon
1059
Black Hills Corp
BKH
$5.69B
$237K 0.03%
3,079
-659
-18% -$45.8K
BRO icon
1060
Brown & Brown
BRO
$23.9B
$237K 0.03%
+3,275
New +$220K
CI icon
1061
Cigna
CI
$74.6B
$237K 0.03%
+989
New +$232K
LYEL icon
1062
Lyell Immunopharma
LYEL
$360M
$237K 0.03%
+2,350
New +$285K
MCHP icon
1063
Microchip Technology
MCHP
$46B
$237K 0.03%
3,149
-3,650
-54% -$275K
CARR icon
1064
Carrier Global
CARR
$52.8B
$236K 0.03%
+5,138
New +$242K
HYFM icon
1065
Hydrofarm Holdings
HYFM
$7.62M
$236K 0.03%
+1,558
New +$291K
IYG icon
1066
iShares US Financial Services ETF
IYG
$2.2B
$236K 0.03%
+3,918
New +$247K
PRTK
1067
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$236K 0.03%
79,448
+27,192
+52% +$102K
IT icon
1068
Gartner
IT
$11.7B
$235K 0.03%
+791
New +$229K
IMDX
1069
Insight Molecular Diagnostics
IMDX
$156M
$235K 0.03%
7,900
-4,715
-37% -$151K
AKAM icon
1070
Akamai
AKAM
$15.9B
$234K 0.03%
+1,962
New +$220K
ALB icon
1071
Albemarle
ALB
$15.5B
$234K 0.03%
+1,060
New +$224K
GFF icon
1072
Griffon
GFF
$4.86B
$234K 0.03%
+11,660
New +$269K
INFU icon
1073
InfuSystem Holdings
INFU
$249M
$234K 0.03%
23,830
-158
-0.7% -$2.03K
JOAN
1074
DELISTED
JOANN, Inc. Common Stock
JOAN
$234K 0.03%
+20,490
New +$231K
AXDX
1075
DELISTED
Accelerate Diagnostics
AXDX
$233K 0.03%
16,208
+10,924
+207% +$311K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.